Symbio Corporation
Biotechnology ResearchOregon, United States2-10 Employees
Symbio Corporation the market leader in interactive heart rhythm simulators for defibrillators, ECG monitors and external pacemakers.
Innovative Leadership Symbio Corporation leads the market in interactive heart rhythm simulators, indicating a strong niche focus on advanced medical training and device testing, which presents opportunities to collaborate with medical device manufacturers and training institutions.
Strategic Partnerships The recent partnership with Cisco Systems to develop unified communications solutions demonstrates the company's commitment to integrating advanced technology solutions, suggesting potential for additional collaborations with healthcare IT integrators and cloud service providers.
Growth Potential With revenue estimates between $1M and $10M and a specialized product portfolio, Symbio appears poised for growth, making it an attractive target for strategic investments or joint ventures in medical simulation and telehealth markets.
Market Niche Focusing on heart rhythm simulation for critical devices, Symbio uniquely positions itself within the medical device sector, indicating sales opportunities with hospitals, emergency services, and medical device OEMs seeking advanced training tools.
Technology Adoption The inclusion of modern tech stack components like PWA and cloud integrations suggests the company is open to adopting and integrating emerging technologies, opening avenues for selling healthcare software solutions and cloud-based simulation tools.
Symbio Corporation uses 8 technology products and services including Cart Functionality, Google Fonts API, YUI, and more. Explore Symbio Corporation's tech stack below.
| Symbio Corporation Email Formats | Percentage |
| First.Last@symbiocorp.com | 50% |
| First.Last@symbiocorp.com | 50% |
Biotechnology ResearchOregon, United States2-10 Employees
Symbio Corporation the market leader in interactive heart rhythm simulators for defibrillators, ECG monitors and external pacemakers.
Symbio Corporation's revenue is estimated to be in the range of $1M$10M
Symbio Corporation's revenue is estimated to be in the range of $1M$10M